ABCC2 and cholestasis: Studies have shown that INH can inhibit SIRT1 deacetylation, thus inactivating FXR, causing Bsep and MRP2-mediated bile transport disorders and bile homeostasis imbalance in the liver, leading to cholestasis (Qu et al., 2018; Zhang W et al., 2020).